Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. The value of a family history to distinguish monogenic from polygenic amyotrophic lateral sclerosis 2026-09-22
  2. Smartphone Passive Digital Phenotyping in Frontotemporal Lobar Degeneration 2026-09-21
  3. Diagnostic Value of Large Language Model-Extracted Gross Brain Findings in Neurodegenerative Diseases 2026-09-14

Studies

1,022 studies carry this tag.

Date range

1967 to 2026

Top journals

  • Neurology 106
  • Brain : a journal of neurology 71
  • Movement disorders : official journal of the Movement Disorder Society 53
  • Annals of neurology 34
  • The Lancet. Neurology 34

313 journals in all.

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. FUS mutations in amyotrophic lateral sclerosis: clinical, pathological, neurophysiological and genetic analysis

    ✓ Peer-reviewed alzhub usefulness score 49 out of 100. Journal of neurology, neurosurgery, and psychiatry 2009-12-03 Brain tissue and pathology

    FUS gene mutations were recently identified in familial amyotrophic lateral sclerosis (ALS).

  2. Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update

    ✓ Peer-reviewed alzhub usefulness score 59 out of 100. Acta Neuropathologica 2009-11-18 Lewy body dementia

  3. Mild cognitive impairment associated with limbic and neocortical Lewy body disease: a clinicopathological study

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Brain : a journal of neurology 2009-11-04 Hippocampus size on brain scans

    These findings indicate that among Lewy body disease cases that pass through a mild cognitive impairment stage, any cognitive pattern or mild cognitive subtype is possible, with the attention/executive and visuospatial domains most frequently impaired.

  4. Clinical syndromes associated with posterior atrophy: early age at onset AD spectrum

    ✓ Peer-reviewed alzhub usefulness score 54 out of 100. Neurology 2009-11-01 Genetics

    Logopenic progressive aphasia and posterior cortical atrophy showed largely overlapping anatomic and biologic features with early age at onset of Alzheimer disease, suggesting that these clinical syndromes represent the spectrum of clinical manifestation of the nontypical form of Alzheimer disease that presents at an early age.

  5. History of falls in Parkinson disease is associated with reduced cholinergic activity

    ✓ Peer-reviewed alzhub usefulness score 57 out of 100. Neurology 2009-11-01 Clinical safety

    Unlike nigrostriatal dopaminergic denervation, cholinergic hypofunction is associated with fall status in Parkinson disease (PD).

  6. Occurrence and risk factors for apathy in Parkinson disease: a 4-year prospective longitudinal study

    ✓ Peer-reviewed alzhub usefulness score 55 out of 100. Journal of neurology, neurosurgery, and psychiatry 2009-11-01 Digital health tools

    Apathy is a persistent behavioural feature in PD with a high incidence and prevalence over time.

  7. The heritability and genetics of frontotemporal lobar degeneration

    ✓ Peer-reviewed alzhub usefulness score 65 out of 100. Neurology 2009-11-01 Getting a diagnosis

    These findings show that frontotemporal lobar degeneration (FTLD) is a highly heritable disorder but heritability varies between the different syndromes.

  8. Urine formaldehyde level is inversely correlated to mini mental state examination scores in senile dementia

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Neurobiology of aging 2009-10-29 Cognitive tests and assessment

    It is widely known that exogenous formaldehyde exposure induces human cognitive impairment and animal memory loss; and recent studies show that formaldehyde at pathological levels induces Aβ deposition and misfolding of tau protein to form globular amyloid-like aggregates.

  9. FUS pathology in basophilic inclusion body disease

    ✓ Peer-reviewed alzhub usefulness score 51 out of 100. Acta neuropathologica 2009-10-15 Brain tissue and pathology

    Basophilic Inclusion Body Disease (BIBD) is a tau-negative form of frontotemporal lobar degeneration (FTLD), characterized by neuronal cytoplasmic inclusions (NCI) that are visible on hematoxylin and eosin stain (HE), contain RNA, and are inconsistently ubiquitin-immunoreactive (ir).

  10. The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort

    ✓ Peer-reviewed alzhub usefulness score 70 out of 100. Brain : a journal of neurology 2009-10-07 Getting a diagnosis

    We have demonstrated that three baseline measures, namely, age >or=72 years, semantic fluency less than 20 words in 90 s and inability to copy an intersecting pentagons figure, are significant predictors of dementia risk, thus validating our previous findings.

  11. Low sensitivity in clinical diagnoses of dementia with Lewy bodies

    ✓ Peer-reviewed alzhub usefulness score 54 out of 100. Journal of neurology 2009-10-01 Long-term cohort studies

    The success of future neurodegenerative disease (ND) therapies depends partly on accurate antemortem diagnoses.

  12. The authors identified 2 Class I studies, 8 Class II studies, and 30 Class III studies in ALS, but many important areas have been little studied.

  13. A clinico-pathological study of subtypes in Parkinson's disease

    ✓ Peer-reviewed alzhub usefulness score 69 out of 100. Brain : a journal of neurology 2009-09-16 Lewy body dementia

    We have carried out a systematic review of the case files of 242 donors with pathologically verified Parkinson's disease at the Queen Square Brain Bank for Neurological Disorders in an attempt to corroborate the data-driven subtype classification proposed by Lewis and colleagues (Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach.

  14. Epidemiology of psychosis in Parkinson's disease

    ✓ Peer-reviewed alzhub usefulness score 54 out of 100. Journal of the neurological sciences 2009-09-08 Caregiving

    Psychotic symptoms are frequent and disabling in patients with Parkinson's disease (PD).

  15. The epidemiology of dementia associated with Parkinson disease

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Journal of the neurological sciences 2009-09-04 Getting a diagnosis

    Several recent studies have shown that dementia is common in Parkinson's disease (PD), and that in some patients, cognitive impairment occurs even at the time of diagnosis.

  16. A new subtype of frontotemporal lobar degeneration with FUS pathology

    ✓ Peer-reviewed alzhub usefulness score 58 out of 100. Brain : a journal of neurology 2009-08-11 Lewy body dementia

    Frontotemporal dementia (FTD) is a clinical syndrome with a heterogeneous molecular basis.

  17. Chronic temporal lobe epilepsy: a neurodevelopmental or progressively dementing disease?

    ✓ Peer-reviewed alzhub usefulness score 57 out of 100. Brain : a journal of neurology 2009-07-27 Brain tissue and pathology

    To what degree does the so-called 'initial hit' of the brain versus chronic epilepsy contribute towards the memory impairment observed in chronic temporal lobe epilepsy (TLE) patients?

  18. Non-Fluent Speech in Frontotemporal Lobar Degeneration

    ✓ Peer-reviewed alzhub usefulness score 49 out of 100. Journal of neurolinguistics 2009-07-01 Digital health tools

    We investigated the cognitive and neural bases of impaired speech fluency, a central feature of primary progressive aphasia.

  19. Cognitive function in early Parkinson's disease: a population-based study

    ✓ Peer-reviewed alzhub usefulness score 50 out of 100. European journal of neurology 2009-06-15 Digital health tools

    Cognitive dysfunction is common in untreated patients in early PD, affecting attention, psychomotor function, episodic memory, executive function and category fluency.

  20. Detecting sarcasm from paralinguistic cues: anatomic and cognitive correlates in neurodegenerative disease

    ✓ Peer-reviewed alzhub usefulness score 46 out of 100. NeuroImage 2009-06-06 Digital health tools

    While sarcasm can be conveyed solely through contextual cues such as counterfactual or echoic statements, face-to-face sarcastic speech may be characterized by specific paralinguistic features that alert the listener to interpret the utterance as ironic or critical, even in the absence of contextual information.

  21. Cognitive impairment in Parkinson's disease: tools for diagnosis and assessment

    ✓ Peer-reviewed alzhub usefulness score 46 out of 100. Movement disorders : official journal of the Movement Disorder Society 2009-06-01 Cognitive tests and assessment

    Cognitive impairment (CI) and dementia are frequent and debilitating features associated with Parkinson's disease (PD).

  22. Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis

    ✓ Peer-reviewed alzhub usefulness score 50 out of 100. Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases 2009-06-01 Getting a diagnosis

    Amyotrophic lateral sclerosis (ALS) is increasingly recognized to be a multisystem disorder which includes both clinical and neuropathological features of a frontotemporal lobar degeneration (FTLD).

  23. Hallucinations in Parkinson disease

    ✓ Peer-reviewed alzhub usefulness score 49 out of 100. Nature reviews. Neurology 2009-06-01 Risk factors

    Patients with Parkinson disease (PD) can experience hallucinations (spontaneous aberrant perceptions) and illusions (misinterpretations of real perceptual stimuli).

  24. Familial aggregation of parkinsonism in progressive supranuclear palsy

    ✓ Peer-reviewed alzhub usefulness score 59 out of 100. Neurology 2009-05-20 Long-term cohort studies

    Progressive supranuclear palsy (PSP) is a progressive neurodegenerative disorder characterized by aggregates of the microtubule-associated protein tau (MAPT).

  25. Refined geographic distribution of the oriental ALDH2*504Lys (nee 487Lys) variant

    ✓ Peer-reviewed alzhub usefulness score 49 out of 100. Annals of human genetics 2009-05-01 Brain tissue and pathology

    Mitochondrial aldehyde dehydrogenase (ALDH2) is one of the most important enzymes in human alcohol metabolism.

  26. Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction

    ✓ Peer-reviewed alzhub usefulness score 59 out of 100. Acta neuropathologica 2009-04-28 Lewy body dementia

    The two current major staging systems in use for Lewy body disorders fail to classify up to 50% of subjects.

  27. Neurodegenerative Diseases Target Large-Scale Human Brain Networks

    ✓ Peer-reviewed alzhub usefulness score 58 out of 100. Neuron 2009-04-01 Brain scans and imaging

    The study used network-sensitive neuroimaging methods to test whether neurodegenerative diseases target large-scale neural networks in living humans.

  28. TARDBP mutations in motoneuron disease with frontotemporal lobar degeneration

    ✓ Peer-reviewed alzhub usefulness score 54 out of 100. Annals of neurology 2009-04-01 Brain tissue and pathology

    TDP-43 (TAR-DNA binding protein) aggregates in neuronal inclusions in motoneuron disease (MND), as well as in frontotemporal lobar degeneration (FTLD) and FTLD associated with MND (FTLD-MND).

  29. The retina in Parkinson's disease

    ✓ Peer-reviewed alzhub usefulness score 52 out of 100. Brain : a journal of neurology 2009-03-31 Risk factors

    As a more complete picture of the clinical phenotype of Parkinson's disease emerges, non-motor symptoms have become increasingly studied.

  30. The dopamine hypothesis of schizophrenia: version III--the final common pathway

    ✓ Peer-reviewed alzhub usefulness score 55 out of 100. Schizophrenia bulletin 2009-03-26 Lewy body dementia

    The dopamine hypothesis of schizophrenia has been one of the most enduring ideas in psychiatry.

  31. Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease

    ✓ Peer-reviewed alzhub usefulness score 64 out of 100. Brain : a journal of neurology 2009-03-13 Risk factors

    Mutations in the glucocerebrosidase gene (GBA) are associated with Gaucher's disease, the most common lysosomal storage disorder.

  32. Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges

    ✓ Peer-reviewed alzhub usefulness score 54 out of 100. The Lancet. Neurology 2009-03-01 Getting a diagnosis

    Progressive supranuclear palsy (PSP) is a clinical syndrome comprising supranuclear palsy, postural instability, and mild dementia.

  33. Can progressive and non-progressive behavioural variant frontotemporal dementia be distinguished at presentation?

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Journal of neurology, neurosurgery, and psychiatry 2009-02-18 Digital health tools

    Progressive and non-progressive patients are difficult to differentiate on the basis of current clinical diagnostic criteria for FTD but a combination of general cognitive, executive dysfunction and impaired ADL measures appear to be the most promising discriminators.

  34. Clinicopathological characterization of Pick's disease versus frontotemporal lobar degeneration with ubiquitin/TDP-43-positive inclusions

    ✓ Peer-reviewed alzhub usefulness score 44 out of 100. Acta neuropathologica 2009-02-05 Digital health tools

    Although frontotemporal lobar degeneration with ubiquitin/TDP-43-positive inclusions (FTLD-TDP) and Pick's disease are common pathological substrates in sporadic FTLD, clinical differentiation of these diseases is difficult.

  35. Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members

    ✓ Peer-reviewed alzhub usefulness score 60 out of 100. Brain : a journal of neurology 2009-01-21 Lewy body dementia

    Mutations in the progranulin gene (GRN) are an important cause of frontotemporal lobar degeneration (FTLD) with ubiquitin and TAR DNA-binding protein 43 (TDP43)-positive pathology.

  36. Neuroanatomy and pathology of sporadic Parkinson's disease

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Advances in anatomy, embryology, and cell biology 2009-01-01 Risk factors

    The proteinopathy sporadic Parkinson's disease (sPD) is the second most frequent degenerative disorder of the human nervous system after Alzheimer's disease.

  37. Oxysterols as markers of neurological disease--a review

    ✓ Peer-reviewed alzhub usefulness score 35 out of 100. Scandinavian journal of clinical and laboratory investigation 2009-01-01 Tau biomarkers

    Cholesterol plays a crucial structural role in the brain and local synthesis covers almost all the requirements of the brain.

  38. Cortical PIB binding in Lewy body disease is associated with Alzheimer-like characteristics

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Neurobiology of disease 2008-12-31 Cognitive tests and assessment

    About one fourth of Lewy body disease (LBD) patients show cortical beta-amyloid load, basically a hallmark of Alzheimer disease (AD).

  39. Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder

    ✓ Peer-reviewed alzhub usefulness score 62 out of 100. Neurology 2008-12-24 Getting a diagnosis

    Although we have found a slightly lower risk than other reports, the risk of developing neurodegenerative disease in idiopathic REM sleep behavior disorder is substantial, with the majority of patients developing Parkinson disease and Lewy body dementia.

  40. Apraxia of speech and nonfluent aphasia: a new clinical marker for corticobasal degeneration and progressive supranuclear palsy

    ✓ Peer-reviewed alzhub usefulness score 46 out of 100. Current opinion in neurology 2008-12-01 Digital health tools

    Recent findings Corticobasal degeneration and PSP are neurodegenerative diseases characterized by neuronal loss and gliosis in cardinal brain regions, as well as the abnormal deposition of the microtubule associated protein tau in cell bodies and cell processes.

  41. Prodromal clinical manifestations of neuropathologically confirmed Lewy body disease

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Neurobiology of aging 2008-11-20 Clinical safety

    The mild cognitive impairment (MCI) stage of dementia with Lewy bodies (MCI-DLB) has not yet been defined, but is likely to differ in the MCI stage of Alzheimer's disease (MCI-AD).

  42. Lymphatic drainage of the brain and the pathophysiology of neurological disease

    ✓ Peer-reviewed alzhub usefulness score 50 out of 100. Acta neuropathologica 2008-11-11 Brain tissue and pathology

    There are no conventional lymphatics in the brain but physiological studies have revealed a substantial and immunologically significant lymphatic drainage from brain to cervical lymph nodes.

  43. A critical evaluation of the Braak staging scheme for Parkinson's disease

    ✓ Peer-reviewed alzhub usefulness score 49 out of 100. Annals of neurology 2008-11-01 Getting a diagnosis

    Braak and colleagues have proposed that, within the central nervous system, Parkinson's disease (PD) begins as a synucleinopathy in nondopaminergic structures of the lower brainstem or in the olfactory bulb.

  44. Executive function in progressive and nonprogressive behavioral variant frontotemporal dementia

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Neurology 2008-11-01 Disparities

    Contrary to some prior reports, behavioral variant frontotemporal dementia (bv-FTD) patients who progress over time are typically impaired on executive tasks at first presentation, although an important minority of true FTD patients perform normally.

  45. Incidence and extent of Lewy body-related alpha-synucleinopathy in aging human olfactory bulb

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Journal of neuropathology and experimental neurology 2008-11-01 Disease mechanisms

    We investigated the incidence and extent of Lewy body (LB)-related alpha-synucleinopathy (LBAS) in the olfactory bulb (OB) in 320 consecutive autopsy patients from a general geriatric hospital (mean age, 81.5 +/- 8.5 years).

  46. Development of methodology for conducting clinical trials in frontotemporal lobar degeneration

    ✓ Peer-reviewed alzhub usefulness score 58 out of 100. Brain : a journal of neurology 2008-10-01 Lewy body dementia

    To design clinical trials for the frontotemporal lobar degenerations (FTLD), knowledge about measurement of disease progression is needed to estimate power and enable the choice of optimal outcome measures.

  47. Prevalence of vitamin d insufficiency in patients with Parkinson disease and Alzheimer disease

    ✓ Peer-reviewed alzhub usefulness score 53 out of 100. Archives of neurology 2008-10-01 Genetics

    This report of 25(OH)D concentrations in a predominantly white PD cohort demonstrates a significantly higher prevalence of hypovitaminosis in PD vs both healthy controls and patients with AD.

  48. White matter tauopathy with globular glial inclusions: a distinct sporadic frontotemporal lobar degeneration

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Journal of neuropathology and experimental neurology 2008-10-01 Disease mechanisms

    Frontotemporal lobar degenerations are a group of disorders characterized by circumscribed degeneration of the frontal and temporal lobes and diverse histopathologic features.

  49. Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis

    ✓ Peer-reviewed alzhub usefulness score 65 out of 100. PLoS genetics 2008-09-19 Lewy body dementia

    The TAR DNA-binding protein 43 (TDP-43) has been identified as the major disease protein in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with ubiquitin inclusions (FTLD-U), defining a novel class of neurodegenerative conditions: the TDP-43 proteinopathies.

  50. VCP disease associated with myopathy, Paget disease of bone and frontotemporal dementia: review of a unique disorder

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Biochimica et biophysica acta 2008-09-18 Brain tissue and pathology

    Inclusion body myopathy (IBM) associated with Paget disease of the bone (PDB) and frontotemporal dementia (FTD) (now called IBMPFD), is a progressive autosomal dominant disorder that was recently identified as being caused by mutations in the VCP (p97 or CDC48) gene which plays a key role in the ubiquitin-proteasome dependent degradation of cytosolic proteins and in the retro translocation of misfolded proteins from the endoplasmic reticulum into the cytoplasm.

From across this tag

10 of the 1,021 studies in this tag, picked by a fixed rule (a hash of each study's address), not by score or date; each page of this list shows a different 10. The same 10 appear here every time.

All topic tags with their study counts